Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025

Company Announcement - Jazz Pharmaceuticals plc will report its 2025 second quarter financial results on August 5, 2025, after the U.S. financial markets close [1] - A live audio webcast will be hosted by company management at 4:30 p.m. EDT / 9:30 p.m. IST to discuss the financial results and provide a business update [1] Registration and Replay Information - Interested parties can register for the call in advance through the Investors section of the Jazz Pharmaceuticals website [2] - It is recommended that participants register at least 15 minutes prior to the scheduled webcast to ensure a timely connection [2] - A replay of the webcast will be available on the Investors section of the Jazz Pharmaceuticals website [2] Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on innovating to transform the lives of patients with serious diseases [3] - The company has a diverse portfolio of marketed medicines, including therapies for sleep disorders, epilepsy, and a growing portfolio of cancer treatments [3] - Jazz Pharmaceuticals is headquartered in Dublin, Ireland, with research and development laboratories and manufacturing facilities in multiple countries [3]